Drug
Nerigliatin clinical trials
Also written PF-04937319.
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
- PF-04937319
- 3
Studies by the year they started
9 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses nerigliatin is read from its arms, and is right about nine times in ten.
Testing it · 9
- A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes MellitusCompletedPhase 1PfizerNCT01044537Written as PF-04937319
- Multiple Dose Study Of PF-04937319 In Patients With Type 2 DiabetesCompletedPhase 1PfizerNCT01272804Written as PF-04937319
- Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On MetforminCompletedPhase 2PfizerNCT01517373Written as PF-04937319 10 mg
- Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 DiabetesCompletedPhase 2PfizerNCT01475461Written as PF-04937319 - 3mg
- Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 DiabetesCompletedPhase 1PfizerNCT01933672Written as PF-04937319 once-daily
- A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As MonotherapyCompletedPhase 1PfizerNCT02292433Written as PF-04937319 high dose
- Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.CompletedPhase 1PfizerNCT02206607Written as PF-04937319 IR MST
- A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy SubjectsCompletedPhase 1PfizerNCT01513928Written as Pf-04937319
- A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy SubjectsCompletedPhase 1PfizerNCT01468714Written as PF-04937319 / ketoconazole
Codes
What other systems call nerigliatin · ClinicalTrials.gg INT000236
- UNII (FDA) 7E99B9ZM19NERIGLIATINOne source FDA
- NCI Thesaurus C203200NerigliatinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 7E99B9ZM19 | NERIGLIATIN | One source FDA |
| NCI Thesaurus | C203200 | Nerigliatin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.